Skip to main content

Table 3 Reported treatment for cardiovascular risk factors

From: Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study

CV risk factor

Treatment

Responders with reported risk factor reporting receiving treatment

p

 

RA

PsA

 
 

N (%)

N (%)

 

Hypertension

Pharmacological

259/279 (92.8)

50/53 (94.3)

0.7

Diabetes

Diet and/or pharmacological

73/73 (100.0)

14/14 (100.0)

N/A

Hyperlipidaemia

Pharmacological

109/157 (69.4)

19/26 (73.1)

0.7

Overweight or obese

Any dietary change in the last year

151/564 (26.8)

36/131 (27.5)

0.9

Commercial weight loss program

21/564 (3.7)

3/131 (2.3)

0.4

Health professional weight loss program

44/564 (7.8)

7/131 (5.3)

0.3

Meal replacements

53/564 (9.4)

10/131 (7.6)

0.5

Exercise program

57/564 (10.1)

11/131 (8.4)

0.6

Bariatric surgery

4/564 (0.7)

1/131 (0.8)

0.9

  1. Treatment for hypertension, diabetes, hyperlipidaemia and being overweight or obese in RA and PsA respondents to the Heart Survey and a comparison of the two disease groups
  2. CV cardiovascular, RA rheumatoid arthritis, PsA psoriatic arthritis, N/A not applicable